Do TNF-blockers reduce or induce uveitis?

Rheumatology

Volumn 47, Issue 5, 2008, Pages 731-732

  Cobo Ibanez T ^a   del Carmen Ordonez M ^a   Munoz Fernandez S ^a   Madero Prado, R ^a   Martin Mola E ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ETANERCEPT; HLA B27 ANTIGEN; INFLIXIMAB; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; ANALYSIS OF VARIANCE; ANKYLOSING SPONDYLITIS; CLINICAL EFFECTIVENESS; DISEASE DURATION; DISEASE EXACERBATION; DRUG EFFICACY; DRUG EXPOSURE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FISHER EXACT TEST; HUMAN; IRIDOCYCLITIS; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RANK SUM TEST; RECURRENT DISEASE; RETROSPECTIVE STUDY; SPONDYLOARTHROPATHY; TREATMENT DURATION;

ADULT; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; ODDS RATIO; RECEPTORS, TUMOR NECROSIS FACTOR; RETROSPECTIVE STUDIES; SPONDYLITIS, ANKYLOSING; TUMOR NECROSIS FACTOR-ALPHA; UVEITIS;

EID: 42949127087     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken091     Document Type: Letter

References (10)

1. Braun J, Baraliakos X, Listing J, Sieper J. Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept. Arthritis Rheum 2005;52:2447-51.
2. Galor A, Perez VL, Hammel JP, Lowder CY. Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation. Ophthalmology 2006;113: 2317-23.
3. Saurenmann RK, Levin AV, Rose JB et al. Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis. Rheumatology 2006;45:982-9.
4. Tynjälä P, Lindahl P, Honkanen V, Lahdenne P, Kotaniemi K. Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritis. Ann Rheum Dis 2007;66:548-50.
5. Lim LL, Fraunfelder FW, Rosenbaum JT. Do tumor necrosis factor inhibitors cause uveitis? A registry-based study. Arthritis Rheum 2007;56:3248-52.
6. Guignard S, Gossec L, Salliot C et al. Efficacy of tumor necrosis factor blockers in reducing uveitis flares in patients with spondylarthropathy: A retrospective study. Ann Rheum Dis 2006;65:163-4.
7. Schmeling H, Homeff G. Etanercept and uveitis in patients with juvenile idiopathic arthritis. Rheumatology 2005;44:1008-11.
8. Smith JA, Thompson DJ, Whitcup SM et al. A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis. Arthritis Rheum 2005;53:18-23.
9. Taban M, Dupps WJ, Mandell B, Perez VL. Etanercept (enbrel)-associated inflammatory eye disease: Case report and review of the literature. Ocul Immunol Inflamm 2006;14:145-50.
10. Rosenbaum JT. Effect of etanercept on iritis in patients with ankylosing spondylitis. Arthritis Rheum 2004;50:3736-7.